cytoskeleton reorganization and cell shape changes in terms of lamellipodia formation in KO VSMCs compared with WT VSMCs. Conclusions: These findings suggest that CHF1/Hey2 is an important regulator of VSMC motility during vascular remodeling through control of PDGF and HB-EGF dependent signaling pathways. p=0.007) compared to GG+GT. However, no association between G894T polymorphism and premature MI was observed in male non-smokers and in female smokers or non-
Background: Oxidation of LDL has emerged as the initiating event in cardiovascular lesion formation. Little is known about the molecular mechanisms linking Ox-LDL and vascular smooth muscle cell accumulation, the harbinger of vascular lesion progression. The HLH transcription factor Id3 is a redox sensitive gene that is expressed in VSMC in response to mitogen stimulation and vascular injury. Id3 is a regulator of growth and differentiation in several other cell types. Accordingly we hypothesize that Id3 is an important mediator of Ox-LDL-induced VSMC growth. Methods: Primary vascular smooth muscle cells were infected with AdId3 or AdGFP control and assayed for cell number, BrdU incorporation and p21 cip1 expression by Western Background: Elevations in serum cardiac troponins have been found to occur in runners completing long distances.Our objectives were to determine prevalence of and risk factors for troponin elevations in marathon finishers. Methods: Entrants in the 2002 Boston Marathon were recruited the weekend prior to the race, at which time we obtained demographic, health history, and training data. At race completion, we obtained race performance data and serum third-generation troponin T (cTnT) and I (cTnI) levels. Potential risk factors for troponin elevations were selected a priori from clinical suspicion and literature review and were evaluated using logistic regression analysis.
Results: A total of 482 runners completed surveys and had labs drawn. In all, 33% were female, 20% were aged <30 years, and 92% had run at least one prior marathon. Compared to males, females were significantly younger (p<0.001), slower (p<0.001), and less experienced marathoners (p=0.018). The majority of marathon runners in our cohort (68%) had some degree of troponin elevation after completing the marathon (cTnT>0.01 ng/mL or cTnI>0.1 ng/mL); of these, 55 (17%) had significant elevations (cTnT >0.075 ng/mL or cTnI>0.5 ng/mL). On multivariate analysis, individuals at greatest risk of significant troponin elevations were less experienced marathoners (<5 prior marathons run, O.R. 3.3, 95% C.I. 1.6-6.6, p<0.001) and younger runners (<30 years, O.R. 2.4, 95% C.I. 1.3-4.5 p=0.006). Female gender was a univariate but not multivariate correlate, and health history, anthropometrics, family history, training intensity, and race performance were not associated. Young age and marathon inexperience were robust predictors of troponin elevations over a broad range of threshold values analyzed and with troponins evaluated as continuous variables.
Conclusion:
In a large and athletically diverse group of marathon finishers, we found that significant troponin elevations were common, and that less experienced marathoners and younger runners were at greatest risk of experiencing elevations. Further prospective research by our group into potential clinical significance of these findings is ongoing. Background: Inflammation in advanced atherosclerotic plaque is a primary catalyst for disruption of the plaque and subsequent thromboembolic events. Thus, a quantitative, non-invasive technique for characterizing inflammation would be invaluable for detecting vulnerable, inflamed plaques and monitoring therapeutic response. We hypothesize that the dynamic response of magnetic resonance imaging (MRI) to an injected gadolinium contrast agent can be used for quantitative evaluation of inflammation by measuring the transfer constant K trans between the blood plasma and the extracellular space. This parameter is derived from the curve of enhancement vs. time and quantifies the increased vascularity, permeability, and extracellular water content associated with the inflammatory response. Methods: The association of K trans with macrophages, the predominant inflammatory cells in human carotid atherosclerotic plaque, was evaluated in 18 carotid endarterectomy patients. Within one week prior to surgery, cross-sectional MRI scans centered at the carotid bifurcation of each patient were performed using a dynamic protocol (fast spoiled gradient echo; 15 seconds per image; 10 time frames), which included injection of 0.1 mmol/kg of a standard, low molecular weight gadolinium contrast agent. Kinetic modelling of the MRI results was used to estimate K trans and the fractional plasma volume v p of the plaque. After surgery, the endarterectomy specimens were sectioned, matched to the MRI results, and double-stained for macrophages (HAM56) and vascular endothelial cells (Ulex, to mask cross-labelling by HAM56). The relative area of each specimen staining positive for macrophages was measured and normalized by the total plaque area. Results: Macrophage content of the excised specimens was found to correlate strongly with K trans (R= 0.74, p=0 .0005) as measured by MRI. Conclusion: K trans serves as a powerful marker of inflammation for clinical evaluation of atherosclerotic plaque. The strong correlation suggests it can be used to measure therapeutic response aimed at reducing plaque inflammation.
